BioPharma Credit PLC

US$0.99As of Sun 8 Nov 2026, 12:00 UTC
LSE:BPCRFinancials
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR 9.06%
Div yield 7.12%
ROE 9.39%
Asset Management
Beta (5Y) 0.17
PE TTM 10.30
TSR TTM 20.23%
Mkt cap US$830.1M
ROIC 5.87%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.20
21.62%
24.48%
Hold 10|4|1|6|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.02
0.02
3.39%
(6.28%)
1.72%
10.01%
Revenue$M
53.93
54.40
56.50
56.42
7.46%
3.78%
2.72%
2.79%
Peers (US$830.1M)
Cap (US$)
PE
879.6M
4.815x
828.8M
8.039x
Capital
TTM
5Y
10Y
Leveragex
1.796
0.198
0.180
EBIT/Intx
3.594
0.314
0.439
Own earn%
(138.39)
185.48
134.99
Sh yield%
30.99
34.59
32.41
Owners
Insiders/Inst%
8.09
62.59
Short interest%
5.53
SBC / revenue%
2.42
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
30–35
$1 testx
—
Incr. ROIC%
6